Fundraising Fox
Oncostellae
Galicia, ES · Founded 2013 · 8 employees on LinkedIn · 3 known investors
Find your way into Oncostellae
Sign up to see every warm intro you have to Oncostellae
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncostellae team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oncostellae is a biotech company developing novel JAK inhibitors for the treatment of inflammatory bowel disease and cancer, with a focus on local, gut-restricted therapies that minimize systemic toxicity.
Investors · 3
In the news
Frequently asked questions
- What does Oncostellae do?
- Oncostellae is a biotech company developing novel JAK inhibitors for the treatment of inflammatory bowel disease and cancer, with a focus on local, gut-restricted therapies that minimize systemic toxicity.
- Who are Oncostellae's investors?
- Oncostellae's investors include Capital Cell, Inveready Technology Investment Group, Unirisco Galicia.
- Where is Oncostellae headquartered?
- Oncostellae is headquartered in Galicia, ES.